Ezproz-D 40 Capsule PR is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, designed to provide effective relief from gastrointestinal disorders. Domperidone acts as a prokinetic agent, enhancing gastric motility and accelerating the emptying of stomach contents, which helps alleviate symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying. Esomeprazole, a proton pump inhibitor, works by reducing the production of stomach acid, thereby promoting healing of acid-related damage in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The combination of these two active ingredients offers a dual mechanism of action, addressing both the excessive acid secretion and impaired gastric motility, making Ezproz-D 40 Capsule PR effective in managing symptoms of acid reflux, indigestion, and gastroparesis. It is typically prescribed for patients who require acid suppression along with improved gastric emptying. The prolonged-release formulation ensures sustained therapeutic levels, enhancing efficacy and patient compliance. As with any medication, it should be used under medical supervision, considering potential contraindications and interactions with other drugs. Ezproz-D 40 Capsule PR is a valuable option for comprehensive management of upper gastrointestinal tract disorders.